Evidence map›Paper›PMID 36831604›Full record

ReviewCancers2023

Neck Surgery for Non-Well Differentiated Thyroid Malignancies: Variations in Strategy According to Histopathology.

Fernando López, Abir Al Ghuzlan, Mark Zafereo, Vincent Vander Poorten, K Thomas Robbins, Marc Hamoir, Iain J Nixon, Ralph P Tufano, Gregory Randolph, Pia Pace-Asciak and 11 more

Open access · goldAbstract readReview
In one paragraph

Review in Cancers, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
0.4field-weighted citation impact, top 36% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed, 3 citations in OpenAlex.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

21 authors at 18 institutions in 12 countries.

Fernando LópezHead and Neck Surgery, Hospital Universitario Central de Asturias (HUCA), 33011 Oviedo, Spain.ORCID 0000-0001-7019-9746
Abir Al GhuzlanDepartment of Biology and Pathology, Gustave Roussy Cancer Campus, University Paris-Saclay, 91190 Villejuif, France.ORCID 0000-0001-5198-6111
Mark ZafereoDepartment of Head and Neck Surgery, The University of Texas M. D. Anderson Cancer Center, Houston, TX 77030, USA.ORCID 0000-0001-7918-9739
Vincent Vander PoortenOtorhinolaryngology Head and Neck Surgery and Department of Oncology, Section Head and Neck Oncology, University Hospitals Leuven, 3000 Leuven, Belgium.ORCID 0000-0003-1341-829X
K Thomas RobbinsDepartment of Otolaryngology-Head and Neck Surgery, Southern Illinois University School of Medicine, Springfield, IL 62702, USA.
Marc HamoirDepartment of Head and Neck Surgery, UC Louvain, St Luc University Hospital and King Albert II Cancer Institute, 1200 Brussels, Belgium.ORCID 0000-0001-8547-2768
Iain J NixonDepartment of Otorhinolaryngology Head and Neck Surgery, NHS Lothian, Edinburgh EH1 3EG, UK.ORCID 0000-0002-8919-8783
Ralph P TufanoFPG Thyroid and Parathyroid Center, Division of Head and Neck Endocrine Surgery, The Sarasota Memorial Health Care System, Sarasota, FL 34239, USA.
Gregory RandolphDivision of Otolaryngology-Endocrine Head and Neck Surgery, Massachusetts Eye and Ear Infirmary, Harvard University, Boston, MA 02138, USA.ORCID 0000-0001-5373-9181
Pia Pace-AsciakDepartment of Otolaryngology-Head and Neck Surgery, University of Toronto, Toronto, ON M5S, Canada.ORCID 0000-0001-9786-3504
Peter AngelosDepartment of Surgery and MacLean Center for Clinical Medical Ethics, The University of Chicago, Chicago, IL 60637, USA.
Andrés Coca-PelazHead and Neck Surgery, Hospital Universitario Central de Asturias (HUCA), 33011 Oviedo, Spain.ORCID 0000-0003-1363-8559
Avi KhafifA.R.M. Center of Otolaryngology-Head and Neck Surgery, Assuta Medical Center, Affiliated with Ben-Gurion University of the Negev, Tel Aviv 8410501, Israel.
Ohad RonenDepartment of Otolaryngology-Head and Neck Surgery, Galilee Medical Center, Affiliated with Azrieli Faculty of Medicine, Bar Ilan University, Safed 5290002, Israel.ORCID 0000-0001-7084-0695
Juan Pablo RodrigoHead and Neck Surgery, Hospital Universitario Central de Asturias (HUCA), 33011 Oviedo, Spain.ORCID 0000-0003-3063-0890
Álvaro SanabriaDepartment of Surgery, Universidad de Antioquia, CEXCA Centro de Excelencia en Enfermedades de Cabeza y Cuello, Medellín 050021, Colombia.ORCID 0000-0002-5563-8840
Carsten E PalmeDepartment of Head and Neck Surgery, Sydney Head and Neck Cancer Institute, Chris O'Brien Lifehouse, Sydney, NSW 2050, Australia.
Antti A MäkitieDepartment of Otorhinolaryngology-Head and Neck Surgery, University of Helsinki and Helsinki University Hospital, FI-00029 Helsinki, Finland.ORCID 0000-0002-0451-2404
Luiz P KowalskiDepartment of Head and Neck Surgery, University of Sao Paulo Medical School, Sao Paulo 01246-903, Brazil.ORCID 0000-0002-0481-156X
Alessandra RinaldoSchool of Medicine, University of Udine, 33100 Udine, Italy.ORCID 0000-0001-7956-6709
Alfio FerlitoCoordinator of International Head and Neck Scientific Group, 35125 Padua, Italy.ORCID 0000-0002-8247-8002
Universidad de Oviedo · ESBar-Ilan University · ILBen-Gurion University of the Negev · ILCliniques Universitaires Saint-Luc · BEERN EURACAN · FRInstitut Gustave Roussy · FRMassachusetts Eye and Ear Infirmary · USNHS Lothian · GBSarasota Memorial Health Care System · USSouthern Illinois University School of Medicine · USThe University of Sydney · AUThe University of Texas MD Anderson Cancer Center · USUniversidad de Antioquia · COUniversidade de São Paulo · BRUniversity of Chicago Medical Center · USUniversity of Helsinki · FIUniversity of Toronto · CAUniversity of Udine · IT

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Lymph node metastases in non-well differentiated thyroid cancer (non-WDTC) are common, both in the central compartment (levels VI and VII) and in the lateral neck (Levels II to V). Nodal metastases negatively affect prognosis and should be treated to maximize locoregional control while minimizing morbidity. In non-WDTC, the rate of nodal involvement is variable and depends on the histology of the tumor. For medullary thyroid carcinomas, poorly differentiated thyroid carcinomas, and anaplastic thyroid carcinomas, the high frequency of lymph node metastases makes central compartment dissection generally necessary. In mucoepidermoid carcinomas, malignant peripheral nerve sheath tumors, sarcomas, and malignant thyroid teratomas or thyroblastomas, central compartment dissection is less often necessary, as clinical lymphnode involvement is less common. We aim to summarize the medical literature and the opinions of several experts from different parts of the world on the current philosophy for managing the neck in less common types of thyroid cancer.

Indexed as

neck dissectionnon-well differentiated thyroid cancerThyroid cancertreatment

Identifiers

PMID36831604
PMCPMC9954150
OpenAlexW4321092769

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.